Detection of genes expressed in primary colon cancers by in situ hybridisation

Overexpression of RACK 1

A. Saito, G. Fujii, Y. Sato, M. Gotoh, Michiie Sakamoto, G. Toda, S. Hirohashi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Aims: The isolation of various genes that are expressed in a region specific manner is considered useful for research in molecular pathology. In situ hybridisation (ISH) was used in a screening procedure to isolate these genes efficiently, using colon cancer as a model. Methods: Suppression subtractive hybridisation (SSH) between colon cancer tissue samples and corresponding non-cancerous tissues was performed. Genes showing high expression in the cancers were selected using macro-DNA array analysis. As a final screening procedure, conventional ISH was performed to isolate genes expressed specifically in colon cancers. Results: Sixty nine clones were selected by SSH and macro-DNA array analyses. These clones were then analysed by ISH to examine their expression patterns. ISH screening revealed that all the clones screened showed more intense signals in colon cancers than in non-cancerous tissues. Among them, RACK 1, which is a protein kinase C receptor and a homologue of the G protein β subunit, was expressed intensely in colon cancer cells. RACK 1 expression was evaluated in multiple samples by ISH, and the results confirmed that RACK 1 was universally overexpressed in cells of all 11 colon cancers examined. Conclusions: Many genes, including RACK 1, expressed in colon cancer cells can be isolated efficiently by this method, and their precise expression pattern can be evaluated. These results indicate that ISH is an excellent technique for systemic screening of genes expressed in a region specific manner.

Original languageEnglish
Pages (from-to)34-39
Number of pages6
JournalJournal of Clinical Pathology - Molecular Pathology
Volume55
Issue number1
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Colonic Neoplasms
In Situ Hybridization
Genes
Clone Cells
Oligonucleotide Array Sequence Analysis
Molecular Pathology
Protein Subunits
GTP-Binding Proteins
Research
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Detection of genes expressed in primary colon cancers by in situ hybridisation : Overexpression of RACK 1. / Saito, A.; Fujii, G.; Sato, Y.; Gotoh, M.; Sakamoto, Michiie; Toda, G.; Hirohashi, S.

In: Journal of Clinical Pathology - Molecular Pathology, Vol. 55, No. 1, 2002, p. 34-39.

Research output: Contribution to journalArticle

@article{83e95b4ee14e423a85546f3db611ab15,
title = "Detection of genes expressed in primary colon cancers by in situ hybridisation: Overexpression of RACK 1",
abstract = "Aims: The isolation of various genes that are expressed in a region specific manner is considered useful for research in molecular pathology. In situ hybridisation (ISH) was used in a screening procedure to isolate these genes efficiently, using colon cancer as a model. Methods: Suppression subtractive hybridisation (SSH) between colon cancer tissue samples and corresponding non-cancerous tissues was performed. Genes showing high expression in the cancers were selected using macro-DNA array analysis. As a final screening procedure, conventional ISH was performed to isolate genes expressed specifically in colon cancers. Results: Sixty nine clones were selected by SSH and macro-DNA array analyses. These clones were then analysed by ISH to examine their expression patterns. ISH screening revealed that all the clones screened showed more intense signals in colon cancers than in non-cancerous tissues. Among them, RACK 1, which is a protein kinase C receptor and a homologue of the G protein β subunit, was expressed intensely in colon cancer cells. RACK 1 expression was evaluated in multiple samples by ISH, and the results confirmed that RACK 1 was universally overexpressed in cells of all 11 colon cancers examined. Conclusions: Many genes, including RACK 1, expressed in colon cancer cells can be isolated efficiently by this method, and their precise expression pattern can be evaluated. These results indicate that ISH is an excellent technique for systemic screening of genes expressed in a region specific manner.",
author = "A. Saito and G. Fujii and Y. Sato and M. Gotoh and Michiie Sakamoto and G. Toda and S. Hirohashi",
year = "2002",
doi = "10.1136/mp.55.1.34",
language = "English",
volume = "55",
pages = "34--39",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Detection of genes expressed in primary colon cancers by in situ hybridisation

T2 - Overexpression of RACK 1

AU - Saito, A.

AU - Fujii, G.

AU - Sato, Y.

AU - Gotoh, M.

AU - Sakamoto, Michiie

AU - Toda, G.

AU - Hirohashi, S.

PY - 2002

Y1 - 2002

N2 - Aims: The isolation of various genes that are expressed in a region specific manner is considered useful for research in molecular pathology. In situ hybridisation (ISH) was used in a screening procedure to isolate these genes efficiently, using colon cancer as a model. Methods: Suppression subtractive hybridisation (SSH) between colon cancer tissue samples and corresponding non-cancerous tissues was performed. Genes showing high expression in the cancers were selected using macro-DNA array analysis. As a final screening procedure, conventional ISH was performed to isolate genes expressed specifically in colon cancers. Results: Sixty nine clones were selected by SSH and macro-DNA array analyses. These clones were then analysed by ISH to examine their expression patterns. ISH screening revealed that all the clones screened showed more intense signals in colon cancers than in non-cancerous tissues. Among them, RACK 1, which is a protein kinase C receptor and a homologue of the G protein β subunit, was expressed intensely in colon cancer cells. RACK 1 expression was evaluated in multiple samples by ISH, and the results confirmed that RACK 1 was universally overexpressed in cells of all 11 colon cancers examined. Conclusions: Many genes, including RACK 1, expressed in colon cancer cells can be isolated efficiently by this method, and their precise expression pattern can be evaluated. These results indicate that ISH is an excellent technique for systemic screening of genes expressed in a region specific manner.

AB - Aims: The isolation of various genes that are expressed in a region specific manner is considered useful for research in molecular pathology. In situ hybridisation (ISH) was used in a screening procedure to isolate these genes efficiently, using colon cancer as a model. Methods: Suppression subtractive hybridisation (SSH) between colon cancer tissue samples and corresponding non-cancerous tissues was performed. Genes showing high expression in the cancers were selected using macro-DNA array analysis. As a final screening procedure, conventional ISH was performed to isolate genes expressed specifically in colon cancers. Results: Sixty nine clones were selected by SSH and macro-DNA array analyses. These clones were then analysed by ISH to examine their expression patterns. ISH screening revealed that all the clones screened showed more intense signals in colon cancers than in non-cancerous tissues. Among them, RACK 1, which is a protein kinase C receptor and a homologue of the G protein β subunit, was expressed intensely in colon cancer cells. RACK 1 expression was evaluated in multiple samples by ISH, and the results confirmed that RACK 1 was universally overexpressed in cells of all 11 colon cancers examined. Conclusions: Many genes, including RACK 1, expressed in colon cancer cells can be isolated efficiently by this method, and their precise expression pattern can be evaluated. These results indicate that ISH is an excellent technique for systemic screening of genes expressed in a region specific manner.

UR - http://www.scopus.com/inward/record.url?scp=0036161615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036161615&partnerID=8YFLogxK

U2 - 10.1136/mp.55.1.34

DO - 10.1136/mp.55.1.34

M3 - Article

VL - 55

SP - 34

EP - 39

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 1

ER -